Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.
Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precision medicine, striving to help the patients through early, accurate and informative diagnoses.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2020 | Series B | $150M | 2 | — | — | Detail |
Mar 27, 2018 | Series A | $60M | 3 | Prosperico Ventures | — | Detail |
Aug 22, 2016 | Series A | $20M | 1 | Lilly Asia Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
FutureX Skyline Capital | — | Series B |
Prosperico Ventures | — | Series B |
UCF Medical Investment | — | Series A |
Lilly Asia Ventures | — | Series A |